Revenue: The sum of all revenue fields included for a company's operating activities.
Prelude Therapeutics Incorporated (PRLD) Revenue data is not available.
| Income Statement Financials | |
|
Revenue |
-- |
$-121.83M |
|
-- |
|
-- |
|
$132.28M |
|
$-132.28M |
|
$10.45M |
|
$-121.83M |
|
$-121.83M |
|
$-121.83M |
|
$-121.83M |
|
$-121.83M |
|
$-121.83M |
|
$-132.28M |
|
$-134.58M |
|
60.36M |
|
60.36M |
|
$-2.02 |
|
$-2.02 |
|
| Balance Sheet Financials | |
$235.59M |
|
$7.33M |
|
$42.08M |
|
$277.67M |
|
$21.83M |
|
-- |
|
$18.75M |
|
$40.58M |
|
$237.09M |
|
$237.09M |
|
$237.09M |
|
54.91M |
|
| Cash Flow Statement Financials | |
$-107.06M |
|
$-34.65M |
|
$136.40M |
|
$34.65M |
|
$29.34M |
|
$-5.31M |
|
$25.62M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-110.58M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-51.39% |
|
-51.39% |
|
-43.88% |
|
-51.39% |
|
$4.32 |
|
$-1.83 |
|
$-1.77 |
|